{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T04:57:38Z","timestamp":1773464258978,"version":"3.50.1"},"reference-count":71,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Portuguese Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia\u2014FCT","doi-asserted-by":"publisher","award":["UIDB\/00009\/2020"],"award-info":[{"award-number":["UIDB\/00009\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Portuguese Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia\u2014FCT","doi-asserted-by":"publisher","award":["UIDP\/0009\/2020"],"award-info":[{"award-number":["UIDP\/0009\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>The altered activity of drug metabolism enzymes (DMEs) is a hallmark of chemotherapy resistance. Cytochrome P450s (CYPs), mainly CYP3A4, and several oxidoreductases are responsible for Phase I metabolism of doxorubicin (DOX), an anthracycline widely used in breast cancer (BC) treatment. This study aimed to investigate the role of Phase I DMEs involved in the first stages of acquisition of DOX-resistance in BC cells. For this purpose, the expression of 92 DME genes and specific CYP-complex enzymes activities were assessed in either sensitive (MCF-7 parental cells; MCF-7\/DOXS) or DOX-resistant (MCF-7\/DOXR) cells. The DMEs genes detected to be significantly differentially expressed in MCF-7\/DOXR cells (12 CYPs and eight oxidoreductases) were indicated previously to be involved in tumor progression and\/or chemotherapy response. The analysis of CYP-mediated activities suggests a putative enhanced CYP3A4-dependent metabolism in MCF-7\/DOXR cells. A discrepancy was observed between CYP-enzyme activities and their corresponding levels of mRNA transcripts. This is indicative that the phenotype of DMEs is not linearly correlated with transcription induction responses, confirming the multifactorial complexity of this mechanism. Our results pinpoint the potential role of specific CYPs and oxidoreductases involved in the metabolism of drugs, retinoic and arachidonic acids, in the mechanisms of chemo-resistance to DOX and carcinogenesis of BC.<\/jats:p>","DOI":"10.3390\/genes13111977","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T04:57:34Z","timestamp":1667105854000},"page":"1977","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Complex Dynamic of Phase I Drug Metabolism in the Early Stages of Doxorubicin Resistance in Breast Cancer Cells"],"prefix":"10.3390","volume":"13","author":[{"given":"Isabel S.","family":"Barata","sequence":"first","affiliation":[{"name":"Centre for Toxicogenomics and Human Health (ToxOmics), Faculdade de Ci\u00eancias M\u00e9dicas (FCM), NOVA Medical School (NMS), Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5632-1095","authenticated-orcid":false,"given":"Bruno C.","family":"Gomes","sequence":"additional","affiliation":[{"name":"Centre for Toxicogenomics and Human Health (ToxOmics), Faculdade de Ci\u00eancias M\u00e9dicas (FCM), NOVA Medical School (NMS), Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8139-4595","authenticated-orcid":false,"given":"Ant\u00f3nio S.","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Centre for Toxicogenomics and Human Health (ToxOmics), Faculdade de Ci\u00eancias M\u00e9dicas (FCM), NOVA Medical School (NMS), Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal"}]},{"given":"Jos\u00e9","family":"Rueff","sequence":"additional","affiliation":[{"name":"Centre for Toxicogenomics and Human Health (ToxOmics), Faculdade de Ci\u00eancias M\u00e9dicas (FCM), NOVA Medical School (NMS), Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1362-0076","authenticated-orcid":false,"given":"Michel","family":"Kranendonk","sequence":"additional","affiliation":[{"name":"Centre for Toxicogenomics and Human Health (ToxOmics), Faculdade de Ci\u00eancias M\u00e9dicas (FCM), NOVA Medical School (NMS), Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3046-1313","authenticated-orcid":false,"given":"Francisco","family":"Esteves","sequence":"additional","affiliation":[{"name":"Centre for Toxicogenomics and Human Health (ToxOmics), Faculdade de Ci\u00eancias M\u00e9dicas (FCM), NOVA Medical School (NMS), Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast Cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.bjc.6605587","article-title":"Influence of Pharmacogenetics on Response and Toxicity in Breast Cancer Patients Treated with Doxorubicin and Cyclophosphamide","volume":"102","author":"Bray","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour Heterogeneity and Resistance to Cancer Therapies","volume":"15","author":"Shaw","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1038\/s41598-017-04250-2","article-title":"Tumoral Expression of Drug and Xenobiotic Metabolizing Enzymes in Breast Cancer Patients of Different Ethnicities with Implications to Personalized Medicine","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/138920112799857549","article-title":"Genomics and Cancer Drug Resistance","volume":"13","author":"Rodrigues","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Rueff, J., and Rodrigues, A.S. (2016). Cancer Drug Resistance: A Brief Overview from a Genetic Viewpoint, Humana Press.","DOI":"10.1007\/978-1-4939-3347-1_1"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/jox11030007","article-title":"The Central Role of Cytochrome P450 in Xenobiotic Metabolism\u2014A Brief Review on a Fascinating Enzyme Family","volume":"11","author":"Esteves","year":"2021","journal-title":"J. Xenobiotics"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Gomes, B.C., Honrado, M., Armada, A., Viveiros, M., Rueff, J., and Rodrigues, A.S. (2020). ABC Efflux Transporters and the Circuitry of MiRNAs: Kinetics of Expression in Cancer Drug Resistance. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082985"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3109\/10428194.2011.584005","article-title":"Development of Imatinib and Dasatinib Resistance: Dynamics of Expression of Drug Transporters ABCB1, ABCC1, ABCG2, MVP, and SLC22A1","volume":"52","author":"Gromicho","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hlav\u00e1\u010d, V., V\u00e1clav\u00edkov\u00e1, R., Brynychov\u00e1, V., Osta\u0161ov, P., Ko\u017eevnikovov\u00e1, R., Kope\u010dkov\u00e1, K., Vr\u00e1na, D., Gat\u011bk, J., and Sou\u010dek, P. (2021). Role of Genetic Variation in Cytochromes P450 in Breast Cancer Prognosis and Therapy Response. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062826"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Jarrar, Y.B., and Lee, S.-J. (2019). Molecular Functionality of Cytochrome P450 4 (CYP4) Genetic Polymorphisms and Their Clinical Implications. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20174274"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molcel.2020.11.024","article-title":"Membrane Damage during Ferroptosis Is Caused by Oxidation of Phospholipids Catalyzed by the Oxidoreductases POR and CYB5R1","volume":"81","author":"Yan","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00003088-200544040-00002","article-title":"Role of Cytochrome P450 Activity in the Fate of Anticancer Agents and in Drug Resistance: Focus on Tamoxifen, Paclitaxel and Imatinib Metabolism","volume":"44","author":"Rochat","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/03602532.2011.560607","article-title":"Toward a New Age of Cellular Pharmacokinetics in Drug Discovery","volume":"43","author":"Zhou","year":"2011","journal-title":"Drug Metab. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1158\/1078-0432.CCR-16-3083","article-title":"Clinically Relevant Concentrations of Anticancer Drugs: A Guide for Nonclinical Studies","volume":"23","author":"Liston","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/cgt.2008.93","article-title":"Potentiation of Methoxymorpholinyl Doxorubicin Antitumor Activity by P450 3A4 Gene Transfer","volume":"16","author":"Lu","year":"2009","journal-title":"Cancer Gene Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1124\/dmd.110.037986","article-title":"Interaction of N-(2-Hydroxypropyl)Methacrylamide Copolymer-Doxorubicin Conjugates with Human Liver Microsomal Cytochromes P450: Comparison with Free Doxorubicin","volume":"39","author":"Masek","year":"2011","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1039\/D1TB00551K","article-title":"The Role of Iron in Doxorubicin-Induced Cardiotoxicity: Recent Advances and Implication for Drug Delivery","volume":"9","author":"Qin","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/sj.onc.1204235","article-title":"Gene Expression and Amplification in Breast Carcinoma Cells with Intrinsic and Acquired Doxorubicin Resistance","volume":"20","author":"Turton","year":"2001","journal-title":"Oncogene"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3892\/ol.2021.12809","article-title":"Cytochrome P450: Implications for Human Breast Cancer (Review)","volume":"22","author":"Luo","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pharmthera.2013.01.010","article-title":"NADPH P450 Oxidoreductase: Structure, Function, and Pathology of Diseases","volume":"138","author":"Pandey","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 Enzymes in Drug Metabolism: Regulation of Gene Expression, Enzyme Activities, and Impact of Genetic Variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2559.2010.03606.x","article-title":"Profiling the Expression of Cytochrome P450 in Breast Cancer: Cytochrome P450 and Breast Cancer","volume":"57","author":"Murray","year":"2010","journal-title":"Histopathology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1097\/MD.0000000000000255","article-title":"The Role of Cytochromes P450 and Aldo-Keto Reductases in Prognosis of Breast Carcinoma Patients","volume":"93","author":"Pecha","year":"2014","journal-title":"Medicine"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Hada, M., Oh, H., Fan, S., Falk, R.T., Geller, B., Vacek, P., Weaver, D., Shepherd, J., Wang, J., and Fan, B. (2020). Relationship of Serum Progesterone and Progesterone Metabolites with Mammographic Breast Density and Terminal Ductal Lobular Unit Involution among Women Undergoing Diagnostic Breast Biopsy. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010245"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1124\/dmd.105.008789","article-title":"Cholesterol-metabolizing Cytochromes P450","volume":"34","author":"Pikuleva","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ijc.31798","article-title":"CYPOR Is a Novel and Independent Prognostic Biomarker of Recurrence-Free Survival in Triple-Negative Breast Cancer Patients","volume":"144","author":"Pedersen","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Brown, G.T., Cash, B.G., Blihoghe, D., Johansson, P., Alnabulsi, A., and Murray, G.I. (2014). The Expression and Prognostic Significance of Retinoic Acid Metabolising Enzymes in Colorectal Cancer. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090776"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7555\/JBR.34.20190111","article-title":"RNA-Seq Analysis Identified Hormone-Related Genes Associated with Prognosis of Triple Negative Breast Cancer","volume":"34","author":"Chen","year":"2020","journal-title":"J. Biomed. Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Liu, X., Jia, Y., Shi, C., Kong, D., Wu, Y., Zhang, T., Wei, A., and Wang, D. (2021). CYP4B1 Is a Prognostic Biomarker and Potential Therapeutic Target in Lung Adenocarcinoma. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0247020"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1074\/mcp.M115.050385","article-title":"NADH-Cytochrome B5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer","volume":"14","author":"Lund","year":"2015","journal-title":"Mol. Cell. Proteom. MCP"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Tsang, Y.-W., Liao, C.-H., Ke, C.-H., Tu, C.-W., and Lin, C.-S. (2021). Integrated Molecular Characterization to Reveal the Association between Kynurenine 3-Monooxygenase Expression and Tumorigenesis in Human Breast Cancers. J. Pers. Med., 11.","DOI":"10.3390\/jpm11100948"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"31350","DOI":"10.18632\/oncotarget.8912","article-title":"CYB5R1 Links Epithelial-Mesenchymal Transition and Poor Prognosis in Colorectal Cancer","volume":"7","author":"Woischke","year":"2016","journal-title":"Oncotarget"},{"key":"ref_34","first-page":"3923","article-title":"Overexpression of Flavin-Containing Monooxygenase 5 Predicts Poor Prognosis in Patients with Colorectal Cancer","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcp.2018.10.006","article-title":"Human Cytochrome P450 Expression in Bacteria: Whole-Cell High-Throughput Activity Assay for CYP1A2, 2A6 and 3A4","volume":"158","author":"Esteves","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Esteves, F., Urban, P., Rueff, J., Truan, G., and Kranendonk, M. (2020). Interaction Modes of Microsomal Cytochrome P450s with Its Reductase and the Role of Substrate Binding. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186669"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1383-5718(99)00032-7","article-title":"Escherichia Coli MTC, a Human NADPH P450 Reductase Competent Mutagenicity Tester Strain for the Expression of Human Cytochrome P450 Isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: Catalytic Activities and Mutagenicity Studies","volume":"441","author":"Kranendonk","year":"1999","journal-title":"Mutat. Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Campelo, D., Esteves, F., Brito Palma, B., Costa Gomes, B., Rueff, J., Lautier, T., Urban, P., Truan, G., and Kranendonk, M. (2018). Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123914"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/mutage\/gei028","article-title":"Escherichia Coli BTC, a Human Cytochrome P450 Competent Tester Strain with a High Sensitivity towards Alkylating Agents: Involvement of Alkyltransferases in the Repair of DNA Damage Induced by Aromatic Amines","volume":"20","author":"Duarte","year":"2005","journal-title":"Mutagenesis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.abb.2008.04.014","article-title":"Impairment of Human CYP1A2-Mediated Xenobiotic Metabolism by Antley-Bixler Syndrome Variants of Cytochrome P450 Oxidoreductase","volume":"475","author":"Kranendonk","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1087057107312780","article-title":"Quantitative Whole-Cell Cytochrome P450 Measurement Suitable for High-Throughput Application","volume":"13","author":"Johnston","year":"2008","journal-title":"J. Biomol. Screen."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fphar.2020.00299","article-title":"The Role of the FMN-Domain of Human Cytochrome P450 Oxidoreductase in Its Promiscuous Interactions With Structurally Diverse Redox Partners","volume":"11","author":"Esteves","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_44","first-page":"478","article-title":"Functional Characterization of Eight Human Cytochrome P450 1A2 Gene Variants by Recombinant Protein Expression","volume":"10","author":"Palma","year":"2010","journal-title":"Pharm. J."},{"key":"ref_45","first-page":"375","article-title":"Interindividual Variability of CYP2C19-Catalyzed Drug Metabolism Due to Differences in Gene Diplotypes and Cytochrome P450 Oxidoreductase Content","volume":"16","author":"Shirasaka","year":"2016","journal-title":"Pharm. J."},{"key":"ref_46","first-page":"1493","article-title":"Comparison between Cytochrome P450 (CYP) Content and Relative Activity Approaches to Scaling from CDNA-Expressed CYPs to Human Liver Microsomes: Ratios of Accessory Proteins as Sources of Discrepancies between the Approaches","volume":"28","author":"Venkatakrishnan","year":"2000","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"ref_47","first-page":"1552","article-title":"Characterization of Interintestinal and Intraintestinal Variations in Human CYP3A-Dependent Metabolism","volume":"283","author":"Paine","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Jhajra, S., Ramesh Varkhede, N., Suresh Ahire, D., Vidyasagar Naik, B., Prasad, B., Paliwal, J., and Singh, S. (2012). Extrahepatic Drug-Metabolizing Enzymes and Their Significance. Encyclopedia of Drug Metabolism and Interactions, John Wiley & Sons, Inc.","DOI":"10.1002\/9780470921920.edm028"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/dmd.121.000638","article-title":"Broad Application of CYP3A4 Liquid Chromatography-Mass Spectrometry Protein Quantification in Hepatocyte Cytochrome P450 Induction Assays Identifies Nonuniformity in MRNA and Protein Induction Responses","volume":"50","author":"Savaryn","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ung, Y.T., Ong, C.E., and Pan, Y. (2018). Current High-Throughput Approaches of Screening Modulatory Effects of Xenobiotics on Cytochrome P450 (CYP) Enzymes. High-Throughput, 7.","DOI":"10.3390\/ht7040029"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Donato, M.T., and G\u00f3mez-Lech\u00f3n, M.J. (2013). Fluorescence-Based Screening of Cytochrome P450 Activities in Intact Cells, Humana Press.","DOI":"10.1007\/978-1-62703-321-3_12"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/bdd.374","article-title":"Rapid Determination of Enzyme Activities of Recombinant Human Cytochromes P450, Human Liver Microsomes and Hepatocytes","volume":"24","author":"Ghosal","year":"2003","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_53","first-page":"95","article-title":"Gene Signatures and Potential Therapeutic Targets of Amino Acid Metabolism in Estrogen Receptor-Positive Breast Cancer","volume":"10","author":"Wang","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/onc.2009.414","article-title":"Oncogenic and Cell Survival Properties of the Retinoic Acid Metabolizing Enzyme, CYP26A1","volume":"29","author":"Osanai","year":"2010","journal-title":"Oncogene"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"102717","DOI":"10.1016\/j.ebiom.2020.102717","article-title":"Kynurenine 3-Monooxygenase Upregulates Pluripotent Genes through \u03b2-Catenin and Promotes Triple-Negative Breast Cancer Progression","volume":"54","author":"Huang","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00280-020-04181-2","article-title":"Involvement of Cytochrome P450 Enzymes in Inflammation and Cancer: A Review","volume":"87","author":"Stipp","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pharmthera.2018.11.009","article-title":"Cytochrome P450 Epoxygenases and Cancer: A Genetic and a Molecular Perspective","volume":"196","author":"Sausville","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and Cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1742-4658.2011.08432.x","article-title":"Cytochrome P450s in the Synthesis of Cholesterol and Bile Acids\u2014From Mouse Models to Human Diseases: CYPs in Cholesterol and BA Synthesis","volume":"279","author":"Lorbek","year":"2012","journal-title":"FEBS J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13058-019-1124-1","article-title":"Updating the Role of Obesity and Cholesterol in Breast Cancer","volume":"21","year":"2019","journal-title":"Breast Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Morgan, E.T. (2017). Regulation of Drug-Metabolizing Enzymes and Drug Metabolism by Inflammatory Responses. Drug Metabolism in Diseases, Elsevier.","DOI":"10.1016\/B978-0-12-802949-7.00002-X"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1158\/1535-7163.MCT-11-0391","article-title":"CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells","volume":"10","author":"Tan","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/dmd.120.000008","article-title":"Epigenetic Regulation of Differentially Expressed Drug-Metabolizing Enzymes in Cancer","volume":"48","author":"Wang","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"R252","DOI":"10.1186\/bcr784","article-title":"Relationship between Intratumoral Expression of Genes Coding for Xenobiotic-Metabolizing Enzymes and Benefit from Adjuvant Tamoxifen in Estrogen Receptor Alpha-Positive Postmenopausal Breast Carcinoma","volume":"6","author":"Girault","year":"2004","journal-title":"Breast Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12020-020-02513-z","article-title":"Microsomal Reductase Activity in Patients with Thyroid Neoplasms","volume":"72","author":"Proskurnina","year":"2021","journal-title":"Endocrine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3945\/ajcn.113.060996","article-title":"\u03b2,\u03b2-Carotene 15,15\u2019-Monooxygenase and Its Substrate \u03b2-Carotene Modulate Migration and Invasion in Colorectal Carcinoma Cells","volume":"98","author":"Pham","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425250903032681","article-title":"The Role of CYP26 Enzymes in Retinoic Acid Clearance","volume":"5","author":"Thatcher","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_68","first-page":"3147","article-title":"The Story of MCF-7 Breast Cancer Cell Line: 40 Years of Experience in Research","volume":"35","author":"Raica","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-4608(99)00158-2","article-title":"Comparative Genomic Hybridization Reveals Extensive Variation among Different MCF-7 Cell Stocks","volume":"117","author":"Jones","year":"2000","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"28994","DOI":"10.1038\/srep28994","article-title":"Genetic Variability in a Frozen Batch of MCF-7 Cells Invisible in Routine Authentication Affecting Cell Function","volume":"6","author":"Kleensang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.tips.2021.09.004","article-title":"Assembling the P450 Puzzle: On the Sources of Nonadditivity in Drug Metabolism","volume":"42","author":"Davydov","year":"2021","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/11\/1977\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:05:31Z","timestamp":1760144731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/11\/1977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":71,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["genes13111977"],"URL":"https:\/\/doi.org\/10.3390\/genes13111977","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,29]]}}}